
    
      This is a prospective, multi-center, single arm, open label, clinical trial. Lesions planned
      to be treated must be declared and recorded at time of enrollment. Planned staged procedures,
      if necessary, must be declared immediately post procedure. Clinical follow-up will be
      performed at 30 days.

      Telephone follow-ups will be performed at 6 months and 1 year post procedure.
    
  